Literature DB >> 27192733

Schedules of Controlled Substances: Temporary Placement of Butyryl Fentanyl and Beta-Hydroxythiofentanyl Into Schedule I. Final order.

.   

Abstract

The Administrator of the Drug Enforcement Administration is issuing this final order to temporarily schedule the synthetic opioids, N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (butyryl fentanyl) and N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide, (beta-hydroxythiofentanyl), and their isomers, esters, ethers, salts and salts of isomers, esters and ethers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of butyryl fentanyl and beta-hydroxythiofentanyl into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, butyryl fentanyl and beta-hydroxythiofentanyl.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27192733

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  4 in total

1.  Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace.

Authors:  Michael H Baumann; Susruta Majumdar; Valerie Le Rouzic; Amanda Hunkele; Rajendra Uprety; Xi Ping Huang; Jin Xu; Bryan L Roth; Ying-Xian Pan; Gavril W Pasternak
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

Review 2.  Misuse of Novel Synthetic Opioids: A Deadly New Trend.

Authors:  Matthew P Prekupec; Peter A Mansky; Michael H Baumann
Journal:  J Addict Med       Date:  2017 Jul/Aug       Impact factor: 3.702

Review 3.  An Expanding World of Novel Psychoactive Substances: Opioids.

Authors:  Jolanta B Zawilska
Journal:  Front Psychiatry       Date:  2017-06-30       Impact factor: 4.157

4.  Systematic review of the clinical consequences of butyrfentanyl and corresponding analogues.

Authors:  Alexander Dinh LE; Saeed Khaled Alzghari
Journal:  Interdiscip Toxicol       Date:  2020-02-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.